A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biochemistry

• Publication date

  2011-05-03

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/bi200113yPMID 21438569PMCID PMC3082593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new family of enzymes catalyzing the first committed step of the methylerythritol 4-phosphate (MEP) pathway for isoprenoid biosynthesis in bacteria

  2010cited by this paper
• Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene.

  2010cited by this paper
• The Global Portfolio of New Antimalarial Medicines Under Development

  2009cited by this paper
• Artemisinin resistance in Plasmodium falciparum malaria.

  2009cited by this paper
• Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum

  2009cited by this paper
• A liquid chromatography-tandem mass spectrometry-based assay for indole-3-acetic acid-amido synthetase.

  2009cited by this paper
• Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates.

  2008cited by this paper
• The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites.

  2008cited by this paper
• Recent highlights in antimalarial drug resistance and chemotherapy research.

  2008cited by this paper
• Towards New Antimalarial Drugs: Synthesis of Non‐Hydrolyzable Phosphate Mimics as Feed for a Predictive QSAR Study on 1‐Deoxy‐D‐xylulose‐5‐phosphate Reductoisomerase Inhibitors

  2008cited by this paper
• WHO report shows progress in efforts to reduce malaria incidence

  2008cited by this paper
• Synthesis of β- and γ-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates

  2008cited by this paper
• The Non-mevalonate Pathway of Isoprenoid Precursor Biosynthesis*

  2007cited by this paper
• The function of terpene natural products in the natural world.

  2007cited by this paper
• Double Ester Prodrugs of FR900098 Display Enhanced In‐Vitro Antimalarial Activity

  2007cited by this paper
• Simultaneous determination of multiple intracellular metabolites in glycolysis, pentose phosphate pathway and tricarboxylic acid cycle by liquid chromatography-mass spectrometry.

  2007cited by this paper
• Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum.

  2007cited by this paper
• Isoprenoid biosynthesis in plants – 2C‐methyl‐d‐erythritol‐4‐phosphate synthase (IspC protein) of Arabidopsis thaliana

  2006cited by this paper
• WHO estimates of the causes of death in children.

  2005cited by this paper
• A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity.

  2004cited by this paper
• The Methylerythritol Phosphate Pathway Is Functionally Active in All Intraerythrocytic Stages of Plasmodium falciparum*

  2004cited by this paper
• Kinetic and chemical mechanism of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate isomeroreductase.

  2004cited by this paper
• The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum

  2003cited by this paper
• E. coli MEP synthase: steady-state kinetic analysis and substrate binding.

  2002cited by this paper
• Isoprenoid biosynthesis via the methylerythritol phosphate pathway. Mechanistic investigations of the 1-deoxy-D-xylulose 5-phosphate reductoisomerase.

  2002cited by this paper
• Structure of 4-diphosphocytidyl-2-C- methylerythritol synthetase involved in mevalonate- independent isoprenoid biosynthesis

  2001cited by this paper
• Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.

  1999cited by this paper
• Construction and characterization of Escherichia coli disruptants defective in the yaeM gene.

  1999cited by this paper
• Apicomplexan plastids as drug targets.

  1999cited by this paper
• Inhibition of bacterial isoprenoid synthesis by fosmidomycin, a phosphonic acid-containing antibiotic.

  1989cited by this paper
• Human malaria parasites in continuous culture.

  1976cited by this paper
• Bmc Microbiology

  year unknowncited by this paper

• Prodrug activation in malaria parasites mediated by an imported erythrocyte esterase, acylpeptide hydrolase (APEH)

  2025influential citation
• Antibiotic fosmidomycin protects bacteria from cell wall perturbations by antagonizing oxidative damage-mediated cell lysis

  2025cites this paper
• A single nucleotide substitution in the SlMCT gene contributes to great morphological alternations in tomato

  2025cites this paper
• Targeting IspD for Anti-infective and Herbicide Development: Exploring Its Role, Mechanism, and Structural Insights

  2025cites this paper
• Host-Derived Geranylgeraniol Shields Intraerythrocytic Stages of Malaria Parasites from Fosmidomycin

  2025cites this paper
• Boron-Containing Analogs of Fosmidomycin: Benzoxaborole Derivatives Exhibit Promising Activity Against Resistant Pathogens

  2025cites this paper
• Emerging Drug Targets for Antimalarial Drug Discovery: Validation and Insights into Molecular Mechanisms of Function.

  2024cites this paper
• Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax

  2024cites this paper
• Inhibition of DXR in the MEP pathway with lipophilic N-alkoxyaryl FR900098 analogs

  2024cites this paper
• Beyond the MEP Pathway: A novel kinase required for prenol utilization by malaria parasites

  2024cites this paper
• Integral Solvent-Induced Protein Precipitation for Target-Engagement Studies in Plasmodium falciparum

  2024cites this paper
• A picomolar inhibitor of the Plasmodium falciparum IPP pathway

  2024cites this paper
• Prodrug activation in malaria parasites mediated by an imported erythrocyte esterase, acylpeptide hydrolase (APEH)

  2024influential citation
• High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of Plasmodium falciparum

  2024cites this paper
• The Multifaceted MEP Pathway: Towards New Therapeutic Perspectives

  2023cites this paper
• MEPicides: α,β-unsaturated Fosmidomycin N-Acyl Analogs as Efficient Inhibitors of Plasmodium falciparum 1-Deoxy-d-xylulose-5-phosphate reductoisomerase.

  2023cites this paper
• The Biomedical Importance of the Missing Pathway for Farnesol and Geranylgeraniol Salvage

  2022cites this paper
• GAPDH mediates drug resistance and metabolism in Plasmodium falciparum malaria parasites

  2022cites this paper
• Apicoplast Journey and Its Essentiality as a Compartment for Malaria Parasite Survival

  2022cites this paper
• Two apicoplast dwelling glycolytic enzymes provide key substrates for metabolic pathways in the apicoplast and are critical for Toxoplasma growth

  2022cites this paper
• Retracted: Exploring Drug Targets in Isoprenoid Biosynthetic Pathway for Plasmodium falciparum

  2022cites this paper
• High-throughput transposon mutagenesis in the family Enterobacteriaceae reveals core essential genes and rapid turnover of essentiality

  2022cites this paper
• Degradation of the Escherichia coli Essential Proteins DapB and Dxr Results in Oxidative Stress, which Contributes to Lethality through Incomplete Base Excision Repair

  2022cites this paper
• New insights into apicoplast metabolism in blood-stage malaria parasites.

  2022cites this paper
• Enzymatic and structural characterization of HAD5, an essential phosphomannomutase of malaria-causing parasites

  2021cites this paper
• Critical role for isoprenoids in apicoplast biogenesis by malaria parasites

  2021cites this paper
• Protein Prenylation and Hsp40 in Thermotolerance of <named-content content-type='genus-species'>Plasmodium falciparum</named-content> Malaria Parasites

  2021influential citation
• Enzymatic and structural characterization of HAD5, an essential phosphomannomutase of malaria parasites

  2021cites this paper
• DXR inhibitory activity of marine fungal methanolic fraction confers protection against vibriosis in Litopenaeus vannamei

  2021cites this paper
• Chemical biology-whole genome engineering datasets predict new antibacterial combinations

  2021cites this paper
• Pharmacotherapy for artemisinin-resistant malaria

  2021cites this paper
• Metabolic Survival Adaptations of Plasmodium falciparum Exposed to Sublethal Doses of Fosmidomycin

  2021cites this paper
• GAPDH cooperativity mediates drug resistance and metabolism in Plasmodium fal-ciparum malaria parasites

  2021cites this paper
• Characterization and Inhibition of 1-Deoxy-d-Xylulose 5-Phosphate Reductoisomerase: A Promising Drug Target in Acinetobacter baumannii and Klebsiella pneumoniae

  2021cites this paper
• The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides

  2020cites this paper
• Biofunctionalization of Textile Materials. 2. Antimicrobial Modification of Poly(lactide) (PLA) Nonwoven Fabricsby Fosfomycin

  2020cites this paper
• Inhibitory Effects of Fosmidomycin Against Babesia microti in vitro

  2020cites this paper
• Synthetic biology, combinatorial biosynthesis, and chemo-enzymatic synthesis of isoprenoids.

  2020cites this paper
• In silico targeting methylerythritol phosphate pathway IspD enzyme of Mycobacterium tuberculosis for novel anti-mycobacterial drug discovery

  2020cites this paper
• Drug targets in the apicoplast

  2020cites this paper
• The Metabolite Repair Enzyme Phosphoglycolate Phosphatase Regulates Central Carbon Metabolism and Fosmidomycin Sensitivity in Plasmodium falciparum

  2019cites this paper
• Comparison of reversed-phase, anion-exchange, and hydrophilic interaction HPLC for the analysis of nucleotides involved in biological enzymatic pathways

  2019cites this paper
• Deciphering structure, function and mechanism of Plasmodium IspD homologs from their evolutionary imprints

  2019cites this paper
• Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering

  2019cites this paper
• Genomic and transcriptional changes in response to pinene tolerance and overproduction in evolved Escherichia coli

  2019cites this paper
• Post-Genomic Approaches to Understanding Malaria Parasite Biology: Linking Genes to Biological Functions.

  2019cites this paper
• Delayed death in the malaria parasite Plasmodium falciparum is caused by disruption of prenylation-dependent intracellular trafficking

  2019cites this paper
• Delayed Death by Plastid Inhibition in Apicomplexan Parasites.

  2019cites this paper
• Proteomic Analysis of Protein–Lipid Modifications: Significance and Application

  2019cites this paper
• Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly

  2019cites this paper
• In vitro Validation of Compounds using Enzymatic Inhibition Assay

  2019cites this paper
• Can Plasmodium’s tricks for enhancing its transmission be turned against the parasite? New hopes for vector control

  2019cites this paper
• Protein Prenylation and Hsp40 in Thermotolerance of Plasmodium falciparum Malaria Parasites

  2019cites this paper
• Recent advances in transmission-blocking drugs for malaria elimination.

  2019cites this paper
• Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination

  2018cites this paper
• The metabolic repair enzyme phosphoglycolate phosphatase regulates central carbon metabolism and fosmidomycin sensitivity in Plasmodium falciparum

  2018cites this paper
• A novel FRET-based screen in high-throughput format to identify inhibitors of malarial and human glucose transporters

  2018cites this paper
• Relict plastidic metabolic process as a potential therapeutic target.

  2018cites this paper
• Deciphering the role of IspD (2‑C‑methyl‑D‑erythritol 4‑phosphate cytidyltransferase) enzyme as a potential therapeutic drug target against Plasmodium vivax.

  2018cites this paper
• Enhancing Production of Pinene in Escherichia coli by Using a Combination of Tolerance, Evolution, and Modular Co-culture Engineering

  2018cites this paper
• Molecular evolution and functional divergence of IspD homologs in malarial parasites.

  2018cites this paper
• Determining the Mode of Action of Antimalarial Drugs Using Time-Resolved LC-MS-Based Metabolite Profiling.

  2018cites this paper
• Suppression of Drug Resistance Reveals a Genetic Mechanism of Metabolic Plasticity in Malaria Parasites

  2018cites this paper
• Genomic Deoxyxylulose Phosphate Reductoisomerase (DXR) Mutations Conferring Resistance to the Antimalarial Drug Fosmidomycin in E. coli.

  2018cites this paper
• Synthesis and Kinetic evaluation of an azido analogue of methylerythritol phosphate: a Novel Inhibitor of E. coli YgbP/IspD

  2018cites this paper
• From the metabolic profiling of drug response to drug mode of action

  2018cites this paper
• CAPi: Computational Model for Apicoplast Inhibitors Prediction Against Plasmodium Parasite.

  2017cites this paper
• Erratum to: New developments in anti-malarial target candidate and product profiles

  2017cites this paper
• MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis

  2017cites this paper
• Balanced activation of IspG and IspH to eliminate MEP intermediate accumulation and improve isoprenoids production in Escherichia coli.

  2017cites this paper
• Specific Inhibition of the Bifunctional Farnesyl/Geranylgeranyl Diphosphate Synthase in Malaria Parasites via a New Small-Molecule Binding Site.

  2017cites this paper
• Chapter Five - The Dark Side of the Chloroplast: Biogenesis, Metabolism and Membrane Biology of the Apicoplast

  2017cites this paper
• Suppressor screen connects HAD protein function to metabolic control in Plasmodium falciparum

  2017cites this paper
• Validation of putative apicoplast targeting drugs using a chemical supplementation 1 assay in cultured human malaria parasites 2 Running title : Apicoplast targeting of a panel of antimalarials

  2017cites this paper
• Metabolic labelling of bacterial isoprenoids produced by the methylerythritol phosphate pathway : a starting point towards a new inhibitor

  2017cites this paper
• New developments in anti-malarial target candidate and product profiles

  2017cites this paper
• In silico polypharmacology of natural products

  2017cites this paper
• Biological Studies and Target Engagement of the 2- C-Methyl-d-Erythritol 4-Phosphate Cytidylyltransferase (IspD)-Targeting Antimalarial Agent (1 R,3 S)-MMV008138 and Analogs.

  2017cites this paper
• Virulence and transcriptome profile of multidrug-resistant Escherichia coli from chicken

  2017cites this paper
• A specific non-bisphosphonate inhibitor of the bifunctional farnesyl/geranylgeranyl diphosphate synthase in malaria parasites

  2017cites this paper
• Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites

  2017cites this paper
• High-throughput enzyme screening platform for the IPP-bypass mevalonate pathway for isopentenol production.

  2017cites this paper
• Whole-Genome Sequencing to Evaluate the Resistance Landscape Following Antimalarial Treatment Failure With Fosmidomycin-Clindamycin.

  2016cites this paper
• Discovery of the Mechanism of Action of Novel Compounds That Target Unicellular Eukaryotic Parasites

  2016cites this paper
• New antibiotics from Nature's chemical inventory.

  2016cites this paper
• The Role of Metabolomics in Antiparasitic Drug Discovery

  2016influential citation
• High-content screening of antimalarial drugs using metabolomic approaches

  2016cites this paper
• Metabolic Dysregulation Induced in Plasmodium falciparum by Dihydroartemisinin and Other Front-Line Antimalarial Drugs.

  2016cites this paper
• A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters

  2016cites this paper
• Modulation of Human and Malarial Glucose Transporter Activity by Lipids and Small Molecules

  2016cites this paper
• Metabolomics-Based Screening of the Malaria Box Reveals both Novel and Established Mechanisms of Action

  2016cites this paper
• Molecular Mechanism of Action of Antimalarial Benzoisothiazolones: Species-Selective Inhibitors of the Plasmodium spp. MEP Pathway enzyme, IspD

  2016cites this paper
• Divergent Isoprenoid Biosynthesis Pathways in Staphylococcus Species Constitute a Drug Target for Treating Infections in Companion Animals

  2016cites this paper
• Muddled mechanisms: recent progress towards antimalarial target identification

  2016cites this paper
• Global proteomic analysis of prenylated proteins in Plasmodium falciparum using an alkyne-modified isoprenoid analogue

  2016cites this paper
• Quantifying the Metabolites of the Methylerythritol 4-Phosphate (MEP) Pathway in Plants and Bacteria by Liquid Chromatography-Triple Quadrupole Mass Spectrometry.

  2016cites this paper
• Untargeted Metabolomics To Ascertain Antibiotic Modes of Action

  2016cites this paper
• Defining the targets of antiparasitic compounds.

  2016cites this paper
• Plasmodium IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target.

  2015cites this paper
• Cap-domain closure enables diverse substrate recognition by the C2-type haloacid dehalogenase-like sugar phosphatase Plasmodium falciparum HAD1.

  2015cites this paper